Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Is The UK The New Sick Man Of Europe?

Published 25/05/2017, 10:19
Updated 18/05/2020, 13:00

UK growth was actually weaker than expected last quarter, rising by a mere 0.2% on a quarterly basis, down from 0.3%. This drags the annual rate down to 2% from 2.1%. The UK is now beginning to look like the sick man of Europe with strong GDP figures for Q1 from Spain this morning, where GDP rose 0.8% on the quarter and 3% on an annualised basis, overall eurozone growth expanded by a 0.5% rate over the first three months’ of the year.

Trade weighs down UK growth figure

Weakness in UK growth was mostly centred in trade, exports were downwardly revised to -1.6%, from 0.5% initially, while imports surged by 2.7%. This suggests that the rebalance away from the consumer is not happening, and the UK’s exporters have not been able to capitalise on the massive 20% devaluation in sterling last year. If the export industry can’t benefit from such a large currency boon, then the sector looks fairly doomed to me.

Some green shoots for business investment

But it wasn’t all bad news. On the bright side, there were some important upward revisions to the GDP report, notably the pick-up in business investment, which jumped by 0.6% in the first quarter after falling 0.9% in the last three months of 2016. Capital spending also rose by 1.2%, which was also revised higher from -0.2% initially. Private consumption was unchanged at 0.3%, and the index of services was revised higher to 0.2% from flat.


This could be a warning sign for Theresa May. If she can’t get a good Brexit deal that protects UK businesses then the UK economy could suffer as other sectors of our economy, like exporters and manufacturers, are not strong enough yet to pick up the slack and drive UK growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

So, is the UK the sick man of Europe?

This growth data isn’t encouraging at the early stage of the Brexit negotiations, however, the fact that the US suffered the same fate and is expected to bounce back later this year is also encouraging and the UK data may follow suit. Added to that, UK corporate earnings for Q1 were strong and beat expectations, thus, if the hard data can follow the corporate data higher then we the weakness in the first quarter GDP could be seen as a slip. At this stage it is too early to call the UK the sick man of Europe, however, another quarter of weak numbers could justify this title.

Why this may not derail GBP/USD on its way above 1.30

The market reaction to this report was muted. A second reading of UK GDP doesn’t tend to set the markets alight. The FTSE is mostly flat on the day, there is hesitancy ahead of the OPEC meeting later today, and European stocks are not following the US market higher, the S&P 500 made another record close on Wednesday.

The pound is hovering around the 1.30 level, although it backed off highs at 1.3015 ahead of the report. We continue to think that the pound could creep higher, after the market slashed their short bets on the pound for yet another week last week. There could also be further upside after momentum indicators backed away from overbought levels, suggesting that there could be room for further sterling upside from a technical perspective.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Disclaimer: The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warrant that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, the author does not guarantee its accuracy or completeness, nor does the author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.